Hoersholm; Denmark February 9, 2016 – Today at 4 p.m., an extraordinary general meeting was convened in Medical Prognosis Institute A/S with the following agenda:
- Resolution on the transfer of the Company’s admittance to trading on Nasdaq First North Denmark to Nasdaq First North Sweden
- Any other business
In accordance with article 11.2 of the Company’s articles of association, the board of directors had appointed Attorney-at-Law Thomas Holst Laursen to chair the general meeting.
Re item 1
The general meeting adopted the proposals of the board of directors.
Re item 2
There were no proposals for discussion under this item.
The board of directors of Medical Prognosis Institute A/S
Venlighedsvej 1, 2970 Hoersholm
Telephone: +45 22 93 08 37/+45 40 14 50 59
For further information, please contact
Peter Buhl Jensen, CEO
Phone: +45 21 60 89 22
Certified Advisor: Carsten Yde Hemme, PricewaterhouseCoopers, Strandvejen 44, 2900 Hellerup, Denmark